The Monoclonal Antibodies market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Monoclonal Antibodies market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Monoclonal Antibodies market.
Key players in the global Monoclonal Antibodies market covered in Chapter 2 and Chapter 6:
Orbit Discovery
Alder BioPharmaceuticals
Esperion Therapeutics Inc.
Medix Biochemica
MRC Laboratory of Molecular
ABLYNX
AbCellera
Alector
Sorrento Therapeutics
Merus
Symphogen
Agenus Inc.
Molecular Partners
NuPathe
Compass Therapeutics
Trianni Inc.
Affimed Therapeutics
Biocon
Aduro Biotech
Amgen
Kymab
Genentech
ADC Therapeutics S?rl
Allakos
Seattle Genetics, Inc.
In Chapter 8 and Chapter 10.3, based on types, the Monoclonal Antibodies market from 2017 to 2029 is primarily split into:
Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Microbial Diseases
Others
In Chapter 9 and Chapter 10.4, based on applications, the Monoclonal Antibodies market from 2017 to 2029 covers:
Subcutaneous
Intravenous
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Monoclonal Antibodies market, containing global revenue and CAGR. The forecast and analysis of Monoclonal Antibodies market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Monoclonal Antibodies. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Monoclonal Antibodies industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Monoclonal Antibodies industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Monoclonal Antibodies in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Monoclonal Antibodies market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Monoclonal Antibodies, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Monoclonal Antibodies market, including the global sales and revenue forecast, regional forecast. It also foresees the Monoclonal Antibodies market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Monoclonal Antibodies
1.2 Monoclonal Antibodies Segment by Type
1.2.1 Global Monoclonal Antibodies Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Cancer
1.2.3 The Market Profile of Autoimmune Diseases
1.2.4 The Market Profile of Inflammatory Diseases
1.2.5 The Market Profile of Infectious Diseases
1.2.6 The Market Profile of Microbial Diseases
1.2.7 The Market Profile of Others
1.3 Global Monoclonal Antibodies Segment by Application
1.3.1 Monoclonal Antibodies Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Subcutaneous
1.3.3 The Market Profile of Intravenous
1.4 Global Monoclonal Antibodies Market, Region Wise (2017-2022)
1.4.1 Global Monoclonal Antibodies Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3 Europe Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.1 Germany Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.2 UK Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.3 France Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.4 Italy Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.5 Spain Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.6 Russia Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.3.7 Poland Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.4 China Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.5 Japan Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.6 India Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8 Latin America Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Monoclonal Antibodies Market Status and Prospect (2017-2022)
1.5 Global Market Size of Monoclonal Antibodies (2017-2029)
1.5.1 Global Monoclonal Antibodies Revenue Status and Outlook (2017-2029)
1.5.2 Global Monoclonal Antibodies Sales Status and Outlook (2017-2029)
2 Global Monoclonal Antibodies Market Landscape by Player
2.1 Global Monoclonal Antibodies Sales and Share by Player (2017-2022)
2.2 Global Monoclonal Antibodies Revenue and Market Share by Player (2017-2022)
2.3 Global Monoclonal Antibodies Average Price by Player (2017-2022)
2.4 Global Monoclonal Antibodies Gross Margin by Player (2017-2022)
2.5 Monoclonal Antibodies Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Monoclonal Antibodies Market Competitive Situation and Trends
2.6.1 Monoclonal Antibodies Market Concentration Rate
2.6.2 Monoclonal Antibodies Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Monoclonal Antibodies Upstream and Downstream Analysis
3.1 Monoclonal Antibodies Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Monoclonal Antibodies Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Monoclonal Antibodies Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Monoclonal Antibodies Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Monoclonal Antibodies
5.3.2 Increased Demand in Emerging Markets
5.4 Monoclonal Antibodies Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Monoclonal Antibodies Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Orbit Discovery
6.1.1 Orbit Discovery Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.1.3 Orbit Discovery Monoclonal Antibodies Market Performance (2017-2022)
6.1.4 Orbit Discovery Business Overview
6.2 Alder BioPharmaceuticals
6.2.1 Alder BioPharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.2.3 Alder BioPharmaceuticals Monoclonal Antibodies Market Performance (2017-2022)
6.2.4 Alder BioPharmaceuticals Business Overview
6.3 Esperion Therapeutics Inc.
6.3.1 Esperion Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.3.3 Esperion Therapeutics Inc. Monoclonal Antibodies Market Performance (2017-2022)
6.3.4 Esperion Therapeutics Inc. Business Overview
6.4 Medix Biochemica
6.4.1 Medix Biochemica Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.4.3 Medix Biochemica Monoclonal Antibodies Market Performance (2017-2022)
6.4.4 Medix Biochemica Business Overview
6.5 MRC Laboratory of Molecular
6.5.1 MRC Laboratory of Molecular Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.5.3 MRC Laboratory of Molecular Monoclonal Antibodies Market Performance (2017-2022)
6.5.4 MRC Laboratory of Molecular Business Overview
6.6 ABLYNX
6.6.1 ABLYNX Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.6.3 ABLYNX Monoclonal Antibodies Market Performance (2017-2022)
6.6.4 ABLYNX Business Overview
6.7 AbCellera
6.7.1 AbCellera Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.7.3 AbCellera Monoclonal Antibodies Market Performance (2017-2022)
6.7.4 AbCellera Business Overview
6.8 Alector
6.8.1 Alector Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.8.3 Alector Monoclonal Antibodies Market Performance (2017-2022)
6.8.4 Alector Business Overview
6.9 Sorrento Therapeutics
6.9.1 Sorrento Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.9.3 Sorrento Therapeutics Monoclonal Antibodies Market Performance (2017-2022)
6.9.4 Sorrento Therapeutics Business Overview
6.10 Merus
6.10.1 Merus Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.10.3 Merus Monoclonal Antibodies Market Performance (2017-2022)
6.10.4 Merus Business Overview
6.11 Symphogen
6.11.1 Symphogen Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.11.3 Symphogen Monoclonal Antibodies Market Performance (2017-2022)
6.11.4 Symphogen Business Overview
6.12 Agenus Inc.
6.12.1 Agenus Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.12.3 Agenus Inc. Monoclonal Antibodies Market Performance (2017-2022)
6.12.4 Agenus Inc. Business Overview
6.13 Molecular Partners
6.13.1 Molecular Partners Basic Information, Manufacturing Base, Sales Area and Competitors
6.13.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.13.3 Molecular Partners Monoclonal Antibodies Market Performance (2017-2022)
6.13.4 Molecular Partners Business Overview
6.14 NuPathe
6.14.1 NuPathe Basic Information, Manufacturing Base, Sales Area and Competitors
6.14.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.14.3 NuPathe Monoclonal Antibodies Market Performance (2017-2022)
6.14.4 NuPathe Business Overview
6.15 Compass Therapeutics
6.15.1 Compass Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
6.15.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.15.3 Compass Therapeutics Monoclonal Antibodies Market Performance (2017-2022)
6.15.4 Compass Therapeutics Business Overview
6.16 Trianni Inc.
6.16.1 Trianni Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.16.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.16.3 Trianni Inc. Monoclonal Antibodies Market Performance (2017-2022)
6.16.4 Trianni Inc. Business Overview
6.17 Affimed Therapeutics
6.17.1 Affimed Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
6.17.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.17.3 Affimed Therapeutics Monoclonal Antibodies Market Performance (2017-2022)
6.17.4 Affimed Therapeutics Business Overview
6.18 Biocon
6.18.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
6.18.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.18.3 Biocon Monoclonal Antibodies Market Performance (2017-2022)
6.18.4 Biocon Business Overview
6.19 Aduro Biotech
6.19.1 Aduro Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
6.19.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.19.3 Aduro Biotech Monoclonal Antibodies Market Performance (2017-2022)
6.19.4 Aduro Biotech Business Overview
6.20 Amgen
6.20.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
6.20.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.20.3 Amgen Monoclonal Antibodies Market Performance (2017-2022)
6.20.4 Amgen Business Overview
6.21 Kymab
6.21.1 Kymab Basic Information, Manufacturing Base, Sales Area and Competitors
6.21.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.21.3 Kymab Monoclonal Antibodies Market Performance (2017-2022)
6.21.4 Kymab Business Overview
6.22 Genentech
6.22.1 Genentech Basic Information, Manufacturing Base, Sales Area and Competitors
6.22.2 Monoclonal Antibodies Product Profiles, Application and Specification
6.22.3 Genentech Monoclonal Antibodies Market Performance (2017-2022)
6.22.4 Genentech Business Overview
6.23 ADC Therapeutics S
Global HD Security Lense Market Growth 2..
HD security cameras are acquisition devices that use ED lens..
+16467917070US (Toll Free)